I Must Be a Geek If I’m This Excited about An Exercise Science Study
Monday, December 15th, 2008
David Helter, General Manager of Ecco Performance in the United States, stole a bit of my thunder when he posted a comment Saturday. David mentioned a scientific study involving the Ecco BIOM that I was planning to tell you about today. At least he didn’t share all the details!
I learned about this study during my recent visit to Ecco headquarters in Denmark. Indeed, I learned about it from Running and Walking Product Manager Alex Nicolai

mere moments before I would have rasied my hand to ask him whether Ecco had plans to perform a study of precisely the nature of the study he told me about, obviating my need to ask. It’s happening at the University of Cologne and being led by renowned running shoe and biomechanics expert Peter Bruggeman. Two hundred runners are participating. For nine months, half of them will do all of their training in Ecco BIOM’s. The other half will wear their shoes of choice. All of the runners will report on any and all injuries sustained during the intervention period.
The purpose of this study is, of course, to determine whether Ecco BIOM’s, thanks to their natural joint motion design, reduce injuries compared to conventional running shoes. I hope that Bruggeman finds they do, because I already believe that minimalist running shoes reduce injury risk, and I want my belief to be validated! I have yearned for somebody to perform a study such as this one since the Nike Free first hit the market. The obvious reason why Nike has not funded such a study is that Nike only manufactures a few minimalist running shoes and a slew of conventional ones, so a positive finding, while a boon to the Free, would be damaging to Nike Running as a whole.
It takes a newcomer to the running market that produces only minimalist running shoes to dare to undertake such an endeavor, and now we have such a player in Ecco. It’s still a daring move, though. Bruggeman can’t be bought; if he finds a negative result he will publish it. And studies as large and long-term as this one are not cheap. I give Ecco major props for respecting truth and belivieving in themselves enough to take this risk. A few of my beloved readers have posted negative comments about the pricetag of the BIOM. Now you have a better understanding why it’s so expensive. Ecco certainly isn’t pricing it at $250 because the company is greedier than New Balance. The BIOM is probably the world’s most expensive running shoe to make. During my visit to Denmark I was mightily impressed by the company’s very real commitment to quality. And really, $250 is nothing.
That said, I won’t see Bruggeman’s proof that the BIOM reduces injury risk compared to other shoes as proof that only the BIOM does so. Instead, I will see it as more or less validating the entire category of minimalist running shoes, the other existing examples of which are much cheaper than the BIOM.
It will be very interesting to see how the market responds to this study, assuming it comes out in Ecco’s favor. I don’t think it will lead to the death of conventional running shoes. These shoes suit the needs of many runners (and non-runners!) just fine, and one mustn’t underestimate the number of runners out there who just love the marshmallow feel of the Brooks Beast and don’t give a shit if it’s the cause of half of their injuries. My best prediction is that minimalist running shoes will eventually becomie a bona fide category that stands alongside the existing ones (cushioned, stability, motion control, etc.) and that every major brand will make and sell them, blithely ignoring the inherent irony of peddling the problem and the solution side-by-side.
http://mattfitzgerald.org/blog/?p=189